chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypoaesthesia, Inflammatory marker test, Magnetic resonance imaging head, Muscular weakness
Clinical narrative: transient global amnesia I had covid 19 last year in NOV 2020 with lot of neurological problems including post covid brain fog and extreme fatigue and muscle aches .I received first dose of phizer vaccine on August 4 2021.Short time after became very confused ,had transient global amnesia for almost 10 hours ,severe headaches brain fog feeling very weak ,right hand weakness some dizziness .difficulty to concentrate and perform my job as a nurse .I checked inflammatory markers which were normal range MRI of brain normal . Covid antybody blood test positive.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, SARS-CoV-2 antibody test, Speech disorder, Transient global amnesia
Clinical narrative: transient global amnesia I had covid 19 last year in NOV 2020 with lot of neurological problems including post covid brain fog and extreme fatigue and muscle aches .I received first dose of phizer vaccine on August 4 2021.Short time after became very confused ,had transient global amnesia for almost 10 hours ,severe headaches brain fog feeling very weak ,right hand weakness some dizziness .difficulty to concentrate and perform my job as a nurse .I checked inflammatory markers which were normal range MRI of brain normal . Covid antybody blood test positive.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Brain fog, Confusional state, Disturbance in attention, Dizziness
Clinical narrative: transient global amnesia I had covid 19 last year in NOV 2020 with lot of neurological problems including post covid brain fog and extreme fatigue and muscle aches .I received first dose of phizer vaccine on August 4 2021.Short time after became very confused ,had transient global amnesia for almost 10 hours ,severe headaches brain fog feeling very weak ,right hand weakness some dizziness .difficulty to concentrate and perform my job as a nurse .I checked inflammatory markers which were normal range MRI of brain normal . Covid antybody blood test positive.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Impaired work ability, Inflammatory marker test, Magnetic resonance imaging head normal
Clinical narrative: transient global amnesia I had covid 19 last year in NOV 2020 with lot of neurological problems including post covid brain fog and extreme fatigue and muscle aches .I received first dose of phizer vaccine on August 4 2021.Short time after became very confused ,had transient global amnesia for almost 10 hours ,severe headaches brain fog feeling very weak ,right hand weakness some dizziness .difficulty to concentrate and perform my job as a nurse .I checked inflammatory markers which were normal range MRI of brain normal . Covid antybody blood test positive.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscular weakness, Myalgia, Nervous system disorder, SARS-CoV-2 antibody test positive, Transient global amnesia
Clinical narrative: transient global amnesia I had covid 19 last year in NOV 2020 with lot of neurological problems including post covid brain fog and extreme fatigue and muscle aches .I received first dose of phizer vaccine on August 4 2021.Short time after became very confused ,had transient global amnesia for almost 10 hours ,severe headaches brain fog feeling very weak ,right hand weakness some dizziness .difficulty to concentrate and perform my job as a nurse .I checked inflammatory markers which were normal range MRI of brain normal . Covid antybody blood test positive.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Syncope
Clinical narrative: -syncope -loss of consciousness
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hyperhidrosis, Malaise, Palpitations
Clinical narrative: Patient stated that she did not feel well. Increased perspiration, felt hot, racing heart. Temperature taken and normal 98.1 degrees Took oral Benadryl and went to ER shortly thereafter.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Hypoaesthesia, Hypopnoea, Peripheral coldness, Syncope
Clinical narrative: About 15 min post vaccination she collapsed on the floor in an iste  without loosing consciousness, she was alert and oriented x3 when I approached her. She complained that she feels weak and her hands and feet feel cold and numb. Her breathing was shallow. 911 was called. While waiting about 25 minutes post vaccination, she developed utricaria around her neck and upper chest area Pt. was alert all the time untill rescue came in. Due to a developing weakness (was unable to get up off the floor without attistance)  rescue desided to follow up taking her to the hospital. She came in to the pharmacy next day. She stayed in the hospital for a few hours and was released home.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: About 15 min post vaccination she collapsed on the floor in an iste  without loosing consciousness, she was alert and oriented x3 when I approached her. She complained that she feels weak and her hands and feet feel cold and numb. Her breathing was shallow. 911 was called. While waiting about 25 minutes post vaccination, she developed utricaria around her neck and upper chest area Pt. was alert all the time untill rescue came in. Due to a developing weakness (was unable to get up off the floor without attistance)  rescue desided to follow up taking her to the hospital. She came in to the pharmacy next day. She stayed in the hospital for a few hours and was released home.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone normal, Brain natriuretic peptide normal, Chest X-ray, Disorientation, Electrocardiogram
Clinical narrative: 12 DAys After Covid VAccine duRing tennis game became nausea, pAle, shaky, disoriented, felt like Ready to pass out 14 dAys After nasuea, sAW yellow spots, felt ready to pass out
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count normal, Metabolic function test normal, Nausea, Pallor, Presyncope
Clinical narrative: 12 DAys After Covid VAccine duRing tennis game became nausea, pAle, shaky, disoriented, felt like Ready to pass out 14 dAys After nasuea, sAW yellow spots, felt ready to pass out
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Troponin normal, Visual impairment
Clinical narrative: 12 DAys After Covid VAccine duRing tennis game became nausea, pAle, shaky, disoriented, felt like Ready to pass out 14 dAys After nasuea, sAW yellow spots, felt ready to pass out
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Loss of personal independence in daily activities, Pain, Pyrexia
Clinical narrative: Pt says she had fever of 101.1 F, headache, body aches. Says she "was flat on back" for 2 days
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Neuropathy peripheral, Paraesthesia
Clinical narrative: tingling in my feet. numbness. pins and needle feelings. diagnosed with neuropathy at the same time as my Covid 19 Pfitzner vaccines. progressively becoming worse unto today.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness after PFIZER Covid-19 booster shot
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blepharospasm, Blood calcium, Computerised tomogram head, Dizziness
Clinical narrative: I received my first Pfizer covid vaccine on 01/30/2021 and second dose 02/20/2021. On 03/13/2021 I begin experiencing muscle twitches initially just in my eyelid and hand then progressed all over my body even internal organs would flutter. It would disrupt sleeping, make tasks difficult and cause anxiety. Twitches peaked in April through May and gradually decreased but remain persist even now, 5 months out. I also had flashes of bright light in my peripheral vision, dizziness and muscle aches in back, neck and extremities with pins and needles sensation. I have seen medical professionals: PCP and neurologists and have had many medical tests performed: labs, CT, X-ray, EMG. All the issues started a few weeks after my 2nd shot and I've been working with medical professionals to resolve it with no real answers or assistance. The medical team could not explain the cause. I'm reporting these adverse side effects to hopefully make things better for others in the future.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Electromyogram, Laboratory test, Loss of personal independence in daily activities, Muscle twitching, Myalgia
Clinical narrative: I received my first Pfizer covid vaccine on 01/30/2021 and second dose 02/20/2021. On 03/13/2021 I begin experiencing muscle twitches initially just in my eyelid and hand then progressed all over my body even internal organs would flutter. It would disrupt sleeping, make tasks difficult and cause anxiety. Twitches peaked in April through May and gradually decreased but remain persist even now, 5 months out. I also had flashes of bright light in my peripheral vision, dizziness and muscle aches in back, neck and extremities with pins and needles sensation. I have seen medical professionals: PCP and neurologists and have had many medical tests performed: labs, CT, X-ray, EMG. All the issues started a few weeks after my 2nd shot and I've been working with medical professionals to resolve it with no real answers or assistance. The medical team could not explain the cause. I'm reporting these adverse side effects to hopefully make things better for others in the future.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Photopsia, Sleep disorder, Visual field defect, Vitamin D
Clinical narrative: I received my first Pfizer covid vaccine on 01/30/2021 and second dose 02/20/2021. On 03/13/2021 I begin experiencing muscle twitches initially just in my eyelid and hand then progressed all over my body even internal organs would flutter. It would disrupt sleeping, make tasks difficult and cause anxiety. Twitches peaked in April through May and gradually decreased but remain persist even now, 5 months out. I also had flashes of bright light in my peripheral vision, dizziness and muscle aches in back, neck and extremities with pins and needles sensation. I have seen medical professionals: PCP and neurologists and have had many medical tests performed: labs, CT, X-ray, EMG. All the issues started a few weeks after my 2nd shot and I've been working with medical professionals to resolve it with no real answers or assistance. The medical team could not explain the cause. I'm reporting these adverse side effects to hopefully make things better for others in the future.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: I received my first Pfizer covid vaccine on 01/30/2021 and second dose 02/20/2021. On 03/13/2021 I begin experiencing muscle twitches initially just in my eyelid and hand then progressed all over my body even internal organs would flutter. It would disrupt sleeping, make tasks difficult and cause anxiety. Twitches peaked in April through May and gradually decreased but remain persist even now, 5 months out. I also had flashes of bright light in my peripheral vision, dizziness and muscle aches in back, neck and extremities with pins and needles sensation. I have seen medical professionals: PCP and neurologists and have had many medical tests performed: labs, CT, X-ray, EMG. All the issues started a few weeks after my 2nd shot and I've been working with medical professionals to resolve it with no real answers or assistance. The medical team could not explain the cause. I'm reporting these adverse side effects to hopefully make things better for others in the future.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: [Janssen covid vaccine (J&J) use for COVID-19 under Emergency Use Authorization (EUA): pt vaccinated 4/10/21 with Janssen - J&J vaccine. tested positive on 8/20/2021. Received Regn-cov2 infusion on 8/25/2021. Currently hospitalized, on oxygen, remdesivir, dexamethasone
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Diet refusal, Emotional distress, Exposure via breast milk, Failure to thrive
Clinical narrative: death; Thrombotic thrombocytopenic purpura/died from Thrombotic Thrombocytopenic Purpura; Failure to thrive; diet refusal/refusing to eat; Emotional Distress/inconsolable; hepatic enzyme increased/elevated liver enzymes; Pyrexia/developed a fever; rash/rash / head to toe rash; Exposure via breast milk; This is spontaneous report from a contactable non-consumer received from a  Regulatory Authority, VAERS Number: 1166062-1). A mother of 5-month-old male patient (breastfeed infant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via transmammary on 17Mar2021, as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The mother was breastfeeding, the patient was exposed via breastmilk. No known allergies were reported. No new exposure aside from mother's vaccination the previous day. On 18Mar2021, patient developed a rash and within 24 hours was inconsolable, refusing to eat and developed a fever, thrombotic thrombocytopenic purpura, failure to thrive, emotional distress, exposure via breast milk and hepatic enzyme increased. The mother brought baby to local ER where assessments were performed, and patient was hospitalized due to the events for 2 days. All the events were considered as serious (fatal), due to hospitalization. Infant was hospitalized but continued to decline and passed away. Diagnosis of TTP. No known allergies. No new exposures aside from the mother's vaccination the previous day. The patient underwent lab tests and procedures which included blood analysis: elevated liver enzymes in Mar2021. On 20Mar2021, patient died. It was not reported if an autopsy was performed.  Follow-up (23Aug2021): This is a follow-up spontaneous report from a Pfizer sponsored Program Corporate (Pfizer) Social Media Platforms. A non-contactable consumer reported for a patient.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021460010 mother case; Reported Cause(s) of Death: Death; Failure to thrive; Thrombotic thrombocytopenic purpura; diet refusal; Emotional Distress; Exposure via breast milk; hepatic enzyme increased; Pyrexia; rash
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hepatic enzyme increased, Pyrexia, Rash, Thrombotic thrombocytopenic purpura
Clinical narrative: death; Thrombotic thrombocytopenic purpura/died from Thrombotic Thrombocytopenic Purpura; Failure to thrive; diet refusal/refusing to eat; Emotional Distress/inconsolable; hepatic enzyme increased/elevated liver enzymes; Pyrexia/developed a fever; rash/rash / head to toe rash; Exposure via breast milk; This is spontaneous report from a contactable non-consumer received from a  Regulatory Authority, VAERS Number: 1166062-1). A mother of 5-month-old male patient (breastfeed infant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via transmammary on 17Mar2021, as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The mother was breastfeeding, the patient was exposed via breastmilk. No known allergies were reported. No new exposure aside from mother's vaccination the previous day. On 18Mar2021, patient developed a rash and within 24 hours was inconsolable, refusing to eat and developed a fever, thrombotic thrombocytopenic purpura, failure to thrive, emotional distress, exposure via breast milk and hepatic enzyme increased. The mother brought baby to local ER where assessments were performed, and patient was hospitalized due to the events for 2 days. All the events were considered as serious (fatal), due to hospitalization. Infant was hospitalized but continued to decline and passed away. Diagnosis of TTP. No known allergies. No new exposures aside from the mother's vaccination the previous day. The patient underwent lab tests and procedures which included blood analysis: elevated liver enzymes in Mar2021. On 20Mar2021, patient died. It was not reported if an autopsy was performed.  Follow-up (23Aug2021): This is a follow-up spontaneous report from a Pfizer sponsored Program Corporate (Pfizer) Social Media Platforms. A non-contactable consumer reported for a patient.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021460010 mother case; Reported Cause(s) of Death: Death; Failure to thrive; Thrombotic thrombocytopenic purpura; diet refusal; Emotional Distress; Exposure via breast milk; hepatic enzyme increased; Pyrexia; rash
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Death, Diet refusal, Emotional distress, Exposure via breast milk
Clinical narrative: death; Thrombotic thrombocytopenic purpura/died from Thrombotic Thrombocytopenic Purpura; Failure to thrive; diet refusal/refusing to eat; Emotional Distress/inconsolable; hepatic enzyme increased/elevated liver enzymes; Pyrexia/developed a fever; rash/rash / head to toe rash; Exposure via breast milk; This is spontaneous report from a contactable non-consumer received from a  Regulatory Authority, VAERS Number: 1166062-1). A mother of 5-month-old male patient (breastfeed infant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via transmammary on 17Mar2021, as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The mother was breastfeeding, the patient was exposed via breastmilk. No known allergies were reported. No new exposure aside from mother's vaccination the previous day. On 18Mar2021, patient developed a rash and within 24 hours was inconsolable, refusing to eat and developed a fever, thrombotic thrombocytopenic purpura, failure to thrive, emotional distress, exposure via breast milk and hepatic enzyme increased. The mother brought baby to local ER where assessments were performed, and patient was hospitalized due to the events for 2 days. All the events were considered as serious (fatal), due to hospitalization. Infant was hospitalized but continued to decline and passed away. Diagnosis of TTP. No known allergies. No new exposures aside from the mother's vaccination the previous day. The patient underwent lab tests and procedures which included blood analysis: elevated liver enzymes in Mar2021. On 20Mar2021, patient died. It was not reported if an autopsy was performed.  Follow-up (23Aug2021): This is a follow-up spontaneous report from a Pfizer sponsored Program Corporate (Pfizer) Social Media Platforms. A non-contactable consumer reported for a patient.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021460010 mother case; Reported Cause(s) of Death: Death; Failure to thrive; Thrombotic thrombocytopenic purpura; diet refusal; Emotional Distress; Exposure via breast milk; hepatic enzyme increased; Pyrexia; rash
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Failure to thrive, Hepatic enzyme increased, Pyrexia, Rash, Thrombotic thrombocytopenic purpura
Clinical narrative: death; Thrombotic thrombocytopenic purpura/died from Thrombotic Thrombocytopenic Purpura; Failure to thrive; diet refusal/refusing to eat; Emotional Distress/inconsolable; hepatic enzyme increased/elevated liver enzymes; Pyrexia/developed a fever; rash/rash / head to toe rash; Exposure via breast milk; This is spontaneous report from a contactable non-consumer received from a  Regulatory Authority, VAERS Number: 1166062-1). A mother of 5-month-old male patient (breastfeed infant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via transmammary on 17Mar2021, as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The mother was breastfeeding, the patient was exposed via breastmilk. No known allergies were reported. No new exposure aside from mother's vaccination the previous day. On 18Mar2021, patient developed a rash and within 24 hours was inconsolable, refusing to eat and developed a fever, thrombotic thrombocytopenic purpura, failure to thrive, emotional distress, exposure via breast milk and hepatic enzyme increased. The mother brought baby to local ER where assessments were performed, and patient was hospitalized due to the events for 2 days. All the events were considered as serious (fatal), due to hospitalization. Infant was hospitalized but continued to decline and passed away. Diagnosis of TTP. No known allergies. No new exposures aside from the mother's vaccination the previous day. The patient underwent lab tests and procedures which included blood analysis: elevated liver enzymes in Mar2021. On 20Mar2021, patient died. It was not reported if an autopsy was performed.  Follow-up (23Aug2021): This is a follow-up spontaneous report from a Pfizer sponsored Program Corporate (Pfizer) Social Media Platforms. A non-contactable consumer reported for a patient.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021460010 mother case; Reported Cause(s) of Death: Death; Failure to thrive; Thrombotic thrombocytopenic purpura; diet refusal; Emotional Distress; Exposure via breast milk; hepatic enzyme increased; Pyrexia; rash
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Limb discomfort, Neurological examination
Clinical narrative: Migraine headaches; Feeling lightheaded; Sensitivity to light; Weakness; Dull sensations in the rightside of body; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 10:00 AM (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The medical history included COVID-19 infection. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 14:00, the patient experienced migraine headaches and had for 1.5 weeks after the vaccine. It was started mild then progressed to where she was feeling lightheaded, sensitivity to light, weakness and dull sensations in the right side of the body. The event resulted in doctor or other healthcare professional office/ clinic visit. No therapeutic measures were taken as a result of reported event. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures, which included PCR (nasal swab) on 22Apr2021 and tested negative. The clinical outcome of the events migraine headaches, feeling lightheaded, sensitivity to light, weakness and dull sensations in the right side of body was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Migraine, Pain, Photophobia
Clinical narrative: Migraine headaches; Feeling lightheaded; Sensitivity to light; Weakness; Dull sensations in the rightside of body; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 10:00 AM (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The medical history included COVID-19 infection. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 14:00, the patient experienced migraine headaches and had for 1.5 weeks after the vaccine. It was started mild then progressed to where she was feeling lightheaded, sensitivity to light, weakness and dull sensations in the right side of the body. The event resulted in doctor or other healthcare professional office/ clinic visit. No therapeutic measures were taken as a result of reported event. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures, which included PCR (nasal swab) on 22Apr2021 and tested negative. The clinical outcome of the events migraine headaches, feeling lightheaded, sensitivity to light, weakness and dull sensations in the right side of body was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Migraine headaches; Feeling lightheaded; Sensitivity to light; Weakness; Dull sensations in the rightside of body; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 10:00 AM (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The medical history included COVID-19 infection. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 14:00, the patient experienced migraine headaches and had for 1.5 weeks after the vaccine. It was started mild then progressed to where she was feeling lightheaded, sensitivity to light, weakness and dull sensations in the right side of the body. The event resulted in doctor or other healthcare professional office/ clinic visit. No therapeutic measures were taken as a result of reported event. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures, which included PCR (nasal swab) on 22Apr2021 and tested negative. The clinical outcome of the events migraine headaches, feeling lightheaded, sensitivity to light, weakness and dull sensations in the right side of body was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Injection site pain
Clinical narrative: Headache; Injection site pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533) via an unspecified route of administration in the right arm on 06Apr2021 at 15:15 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The medical history were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 06Apr2021, the patient experienced headache, injection site pain and fatigue. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, injection site pain and fatigue were recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: Headache; Injection site pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533) via an unspecified route of administration in the right arm on 06Apr2021 at 15:15 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The medical history were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 06Apr2021, the patient experienced headache, injection site pain and fatigue. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, injection site pain and fatigue were recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Lethargy
Clinical narrative: Intermittent headaches; Lethargy; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0170) via an unspecified route of administration in the left arm on 24Apr2021 at 13:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), fexofenadine hydrochloride (ALLEGRA), ibuprofen (MOTRIN) and lysine (MANUFACTURER UNKNOWN), all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 25Apr2021, the patient had intermittent headaches, lethargy and fatigue. Both events started within two days of vaccine and were still present. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event intermittent headaches, lethargy and fatigue was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Injection site pain, Myalgia, Nausea, Pyrexia
Clinical narrative: Injection site pain; Tiredness; Muscle pain; Fever; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 26Apr2021 at 16:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient had no known allergies to medications, food or other products. The patient did not take any other medications within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 05Apr2021 at 16:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 14:00, the patient experienced injection site pain, tiredness, muscle pain, fever and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of th events and included treatment with TYLENOL. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, tiredness, muscle pain, fever and nausea were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Myalgia, Nausea, Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain; Tiredness; Muscle pain; Fever; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 26Apr2021 at 16:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient had no known allergies to medications, food or other products. The patient did not take any other medications within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 05Apr2021 at 16:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 14:00, the patient experienced injection site pain, tiredness, muscle pain, fever and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of th events and included treatment with TYLENOL. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, tiredness, muscle pain, fever and nausea were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Lymphatic swelling in left armpit; Body aches; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 28Apr2021 at 07:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression, high cholesterol, acid reflux (esophageal) and irritable bowel syndrome (IBS). The patient previously took bupropion hydrochloride (WELLBUTRIN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), rosuvastatin (MANUFACTURER UNKNOWN) and etonogestrel (NEXPLANON); all started on an unknown date for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via an unspecified route of administration on 08Apr2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 29Apr2021 at 07:00 the patient experienced lymphatic swelling in left armpit, low grade fever and body aches. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with steroids (MANUFACTURER UNKNOWN). The clinical outcome of the event lymphatic swelling in left armpit, body aches and low-grade fever was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Myalgia
Clinical narrative: Lymphatic swelling in left armpit; Body aches; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 28Apr2021 at 07:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression, high cholesterol, acid reflux (esophageal) and irritable bowel syndrome (IBS). The patient previously took bupropion hydrochloride (WELLBUTRIN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), rosuvastatin (MANUFACTURER UNKNOWN) and etonogestrel (NEXPLANON); all started on an unknown date for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via an unspecified route of administration on 08Apr2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 29Apr2021 at 07:00 the patient experienced lymphatic swelling in left armpit, low grade fever and body aches. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with steroids (MANUFACTURER UNKNOWN). The clinical outcome of the event lymphatic swelling in left armpit, body aches and low-grade fever was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Lymphatic swelling in left armpit; Body aches; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 28Apr2021 at 07:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression, high cholesterol, acid reflux (esophageal) and irritable bowel syndrome (IBS). The patient previously took bupropion hydrochloride (WELLBUTRIN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), rosuvastatin (MANUFACTURER UNKNOWN) and etonogestrel (NEXPLANON); all started on an unknown date for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via an unspecified route of administration on 08Apr2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 29Apr2021 at 07:00 the patient experienced lymphatic swelling in left armpit, low grade fever and body aches. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with steroids (MANUFACTURER UNKNOWN). The clinical outcome of the event lymphatic swelling in left armpit, body aches and low-grade fever was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Gait disturbance, Mobility decreased, Pain in extremity, Peripheral swelling
Clinical narrative: Swollen right ankle, very painful; Swollen right ankle, very painful; This is a spontaneous report from a contactable healthcare professional, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 24Apr2021 at 11:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included propranolol hydrochloride (INDERAL), lisdexamfetamine mesilate (VYVANSE), mirabegron (MYRBETRIC) and ascorbic acid/vitamin d nos (MANUFACTURER UNKNOWN) and "Z PICO"; all for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 03Apr2021 at 11:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 08:00 (Sunday), the patient woke up in the morning with a swollen right ankle, very painful and could not put any weight on the ankle. The patient needed to use crutches. After few days, on Thursday, it was better but still swollen and painful. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen right ankle, very painful was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Joint swelling
Clinical narrative: Swollen right ankle, very painful; Swollen right ankle, very painful; This is a spontaneous report from a contactable healthcare professional, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 24Apr2021 at 11:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included propranolol hydrochloride (INDERAL), lisdexamfetamine mesilate (VYVANSE), mirabegron (MYRBETRIC) and ascorbic acid/vitamin d nos (MANUFACTURER UNKNOWN) and "Z PICO"; all for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 03Apr2021 at 11:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 08:00 (Sunday), the patient woke up in the morning with a swollen right ankle, very painful and could not put any weight on the ankle. The patient needed to use crutches. After few days, on Thursday, it was better but still swollen and painful. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen right ankle, very painful was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Fatigue; Body aches; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 29Apr2021 at 12:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis. The patient had no known allergies to medication, food or any other products. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 02:30, the patient experienced fatigue, body aches, chills and fever. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue, body aches, chills and fever were resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.